Pfizer and the British Society for Antimicrobial Chemotherapy Announce a New Antimicrobial Stewardship RFP

Governance and Public Policy
Well-being, Health and Biomedical Discovery


Academic Unit: inquire with unit

Memorial Deadline: Wednesday 30th, March 2022

External Deadline: Wednesday 6th, April 2022


Request for Proposals (RFP)

Establishing Antimicrobial Stewardship (AMS) Centres of Excellence to Improve Patient Outcomes by Addressing Access Disparities

Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest, sets timelines for review and approval, and uses an expert review panel (ERP) to make final grant decisions. Organizations are invited to submit an application addressing the specific gaps in practice as outlined in the specific RFP.

The British Society for Antimicrobial Chemotherpay (BSAC) is a learned professional organisation providing a portfolio of global education on infection related topics and a leading influencer of responsible antimicrobial use globally.

For all AMS grants, the grant requester (and ultimately the grantee) is responsible for the submission of requested information, engagement with the AMS accreditation process and implementation of identified improvement actions supported by the grant. Pfizer must not and will not be involved in any aspect of project development, nor the conduct or monitoring of the AMS accreditation process.

Date RFP Issued: January 27, 2022

Geographic Scope: Global, covering resource limited settings within both High-Income Country (HIC) and Low- and Middle-Income country (LMIC) settings

Clinical Area: Anti-infectives

Link to full RFP: Establishing Antimicrobial Stewardship (AMS) Centres of Excellence to Improve Patient Outcomes by Addressing Access Disparities

Application Due Date: April 6, 2022

Specific Area of Interest: The purpose of this RFP is to solicit programs that have identified a resource limitation within their healthcare organization that impacts establishment of a holistic and sustainable antimicrobial stewardship (AMS) program. The RFP will support delivery, to successful applicant institutions, of a programme of work to support the development of local AMS programs and will culminate with accreditation of centres and lead to a network of AMS Centres of Excellence across the world that can share learning within their region.

Funding Sources

Pfizer Inc

This opportunity was posted by: RGCS

Last modified: January 28, 2022